Update on the prevention and treatment of sexually transmitted diseases

American Family Physician

Volumn 67, Issue 9, 2003, Pages 1915-1922

  Miller, Karl E ^a   Ruiz, David E ^a   Graves, J Christopher ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFOTAXIME; CEFOXITIN; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; GATIFLOXACIN; HEPATITIS A VACCINE; HEPATITIS B VACCINE; LEVOFLOXACIN; LOMEFLOXACIN; METRONIDAZOLE; NONOXINOL 9; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN;

CHLAMYDIASIS; FEMALE; GENITAL HERPES; GONORRHEA; HEALTH CARE ORGANIZATION; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOMOSEXUALITY; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MALE; NONSPECIFIC URETHRITIS; PATIENT EDUCATION; PRACTICE GUIDELINE; REINFECTION; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; URETHRITIS; VAGINA DISCHARGE;

ANTI-INFECTIVE AGENTS; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HEALTH BEHAVIOR; HUMANS; MALE; PATIENT EDUCATION; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINES; SEXUALLY TRANSMITTED DISEASES; VAGINAL DISCHARGE;

EID: 0037991537     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999;26(4 suppl):S2-7.
2. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-6):1-78.
3. Shrier LA, Ancheta R, Goodman E, Chiou VM, Lyden MR, Emans SJ. Randomized controlled trial of a safer sex intervention for high-risk adolescent girls. Arch Pediatr Adolesc Med 2001;155:73-9.
4. Crosby RA, Newman D, Kamb ML, Zenilman J, Douglas JM Jr, Iatesta M. Misconceptions about STD-protective behavior. Project RESPECT Study Group. Am J Prev Med 2000;19:167-73.
5. Dodge WT, BlueSpruce J, Grothaus L, Rebolledo V, McAfee TA, Carey JW, et al. Enhancing primarycare HIV prevention: a comprehensive clinical intervention. Am J Prev Med 2001;20:177-83.
6. Catania JA, Canchola J, Binson D, Dolcini MM, Paul JP, Fisher L, et al. National trends in condom use among at-risk heterosexuals in the United States. J Acquir Immune Defic Syndr 2001;27:176-82.
7. Aten MJ, Siegel DM, Enaharo M, Auinger P. Keeping middle school students abstinent: outcomes of a primary prevention intervention. J Adolesc Health 2002;31:70-8.
8. Shepherd J, Weston R, Peersman G, Napuli IZ. Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer. Cochrane Database Syst Rev 2000;(2):CD001035.
9. Schmidt RM, Middleman AB. The importance of hepatitis B vaccination among adolescents. J Adolesc Health 2001;29:217-22.
10. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Tweedy KG. Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial. JAMA 2002;287:1117-22.
11. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998;339: 504-10,
12. Richardson BA, Lavreys L, Martin HL Jr, Stevens CE, Ngugi E, Mandaliya K, et al. Evaluation of a lowdose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis 2001;28:394-400.
13. Gevelber MA, Biro FM. Adolescents and sexually transmitted diseases. Pediatr Clin North Am 1999;46:747-66.
14. Miller KE, Graves JC. Update on the prevention and treatment of sexually transmitted diseases. Am Fam Physician 2000;61:379-86.
15. Woodward C, Fisher MA. Drug treatment of common STDs: part I. Herpes, syphilis, urethritis, chlamydia and gonorrhea. Am Fam Physician 1999;60:1387-94.
16. Czelusta A, Yen-Moore A, Van der Straten M, Carrasco D, Tyring SK. An overview of sexually transmitted diseases. Part III. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol 2000;43:409-32.
17. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342:534-40.
18. Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001;97(5 pt 1):643-8.
19. Guise JM, Mahon SM, Aickin M, Helfand M, Peipert JF, Westhoff C. Screening for bacterial vaginosis in pregnancy. Am J Prev Med 2001;20(3 suppl): 62-72.
20. Brocklehurst P, Hannah M, McDonald H. Interventions for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2000;(2):CD000262.
21. Gulmezoglu AM. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev 2002; (3):CD000220.
22. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
23. Sihvo S, Ahonen R, Mikander H, Hemminki E. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns. Fam Pract 2000;17(2):145-9.
24. Peipert JF, Ness RB, Blume J, Soper DE, Holley R, Randall H, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol 2001; 184:856-63.